Well, I certainly wouldn&#x27;t expect a business executive to invest in a drug he suspects will be unprofitable. That aside, if the drug is unprofitable, and society has established as a general principle that the private sector is the appropriate venue for drug manufacturing, then I don&#x27;t understand the objection to a price increase in principle. Without more information, we just don&#x27;t know that this is an instance of price gouging. I&#x27;m open to that possibility, but I suggest waiting for actual evidence before taking your pitchfork out of the shed.